158 related articles for article (PubMed ID: 9237107)
1. Both invariant chain isoforms Ii31 and Ii41 promote class II antigen presentation.
Serwe M; Reuter G; Sponaas A; Koch S; Koch N
Int Immunol; 1997 Jul; 9(7):983-91. PubMed ID: 9237107
[TBL] [Abstract][Full Text] [Related]
2. The Ii41 isoform of invariant chain mediates both positive and negative selection events in T-cell receptor transgenic mice.
Wright RJ; Bikoff EK; Stockinger B
Immunology; 1998 Nov; 95(3):309-13. PubMed ID: 9824491
[TBL] [Abstract][Full Text] [Related]
3. Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain.
Nadimi F; Moreno J; Momburg F; Heuser A; Fuchs S; Adorini L; Hämmerling GJ
Eur J Immunol; 1991 May; 21(5):1255-63. PubMed ID: 2037011
[TBL] [Abstract][Full Text] [Related]
4. C-terminal extension of the MHC class II-associated invariant chain by an antigenic sequence triggers activation of naive T cells.
Sponaas A; Carstens C; Koch N
Gene Ther; 1999 Nov; 6(11):1826-34. PubMed ID: 10602378
[TBL] [Abstract][Full Text] [Related]
5. Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are the predominant antigen presenting cells in vivo.
Qi L; Rojas JM; Ostrand-Rosenberg S
J Immunol; 2000 Nov; 165(10):5451-61. PubMed ID: 11067897
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of invariant chain function in transgenic mice in vivo by individual p31 and p41 isoforms.
Shachar I; Elliott EA; Chasnoff B; Grewal IS; Flavell RA
Immunity; 1995 Sep; 3(3):373-83. PubMed ID: 7553001
[TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin type-I-like domains in invariant chain fusion proteins mediate resistance to cathepsin L digestion.
Hitzel C; Kanzler H; König A; Kummer MP; Brix K; Herzog V; Koch N
FEBS Lett; 2000 Nov; 485(1):67-70. PubMed ID: 11086167
[TBL] [Abstract][Full Text] [Related]
8. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
[TBL] [Abstract][Full Text] [Related]
9. Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II molecules.
Lombard-Platet S; Bertolino P; Gimenez C; Humbert M; Gerlier D; Rabourdin-Combe C
Cell Immunol; 1993 Apr; 148(1):60-70. PubMed ID: 8495491
[TBL] [Abstract][Full Text] [Related]
10. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.
Brooks A; Hartley S; Kjer-Nielsen L; Perera J; Goodnow CC; Basten A; McCluskey J
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3290-4. PubMed ID: 1707537
[TBL] [Abstract][Full Text] [Related]
11. Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74-deficient mice.
Genève L; Chemali M; Desjardins M; Labrecque N; Thibodeau J
Immunol Cell Biol; 2012 Oct; 90(9):896-902. PubMed ID: 22689013
[TBL] [Abstract][Full Text] [Related]
12. Correlation between invariant chain expression level and capability to present antigen to MHC class II-restricted T cells.
Bertolino P; Forquet F; Pont S; Koch N; Gerlier D; Rabourdin-Combe C
Int Immunol; 1991 May; 3(5):435-43. PubMed ID: 1655000
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
Snider DP; Segal DM
J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
[TBL] [Abstract][Full Text] [Related]
14. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41.
Peterson M; Miller J
Nature; 1992 Jun; 357(6379):596-8. PubMed ID: 1608470
[TBL] [Abstract][Full Text] [Related]
15. Truncation of the A alpha chain of MHC class II molecules results in inefficient antigen presentation to antigen-specific T cells.
Wade WF; Ward ED; Rosloniec EF; Barisas BG; Freed JH
Int Immunol; 1994 Oct; 6(10):1457-65. PubMed ID: 7826938
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
17. Threshold detection of self-antigen/MHC class II complexes formed in vivo: constitutive presentation of an immunodominant epitope of hen egg lysozyme (HEL) in HEL-transgenic mice.
Kanost D; Basten A; McCluskey J
Int Immunol; 1993 Aug; 5(8):893-902. PubMed ID: 8398984
[TBL] [Abstract][Full Text] [Related]
18. Truncation of the class II beta-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes.
Smiley ST; Rudensky AY; Glimcher LH; Grusby MJ
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):241-4. PubMed ID: 8552613
[TBL] [Abstract][Full Text] [Related]
19. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain.
Puré E; Inaba K; Crowley MT; Tardelli L; Witmer-Pack MD; Ruberti G; Fathman G; Steinman RM
J Exp Med; 1990 Nov; 172(5):1459-69. PubMed ID: 2121888
[TBL] [Abstract][Full Text] [Related]
20. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]